Prognosis
Moderna’s Covid Shot Gets Regulatory Nod in India for Imports
- Indemnity details still being discussed, official says
- India has fully vaccinated only 4% of its population
Photographer: Stephen Zenner/Bloomberg
This article is for subscribers only.
India’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.
The Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.